Conflict of Interest None declared.
A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians
Article first published online: 3 DEC 2012
© 2012 The Authors. Journal of the European Academy of Dermatology and Venereology © 2012 European Academy of Dermatology and Venereology
Journal of the European Academy of Dermatology and Venereology
Special Issue: The Hype about Hyperpigmentation. Update on Latest Research on Pathogenesis and Treatment Options of Hyperpigmentory Disorders as Melasma and Post-inflammatory Hyperpigmentation and the Evidence on a Novel Inhibitor of Human Tyrosinase: 4-n-Butylresorcinol
Volume 27, Issue Supplement s1, pages 7–18, January 2013
How to Cite
Eimpunth, S., Wanitphadeedecha, R. and Manuskiatti, W. (2013), A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians. Journal of the European Academy of Dermatology and Venereology, 27: 7–18. doi: 10.1111/jdv.12050
- Issue published online: 3 DEC 2012
- Article first published online: 3 DEC 2012
Postinflammatory hyperpigmentation (PIH) is a common consequence following cutaneous inflammation in dark-skinned individuals with Fitzpatrick skin phototypes (SPTs) III–VI. The exact pathogenesis of this condition is unknown, but is believed to be an integral part of the normal response of the skin to inflammatory stimuli. PIH can last from months to years and may significantly impair quality of life of affected individuals. The primary treatment of PIH is prevention and treatment of the underlying inflammatory condition. In addition to prevention, there are a variety of medication and procedures used to treat PIH. Although topical skin-depigmenting agents remain the treatment of choice for PIH, lasers and light sources may be an effective adjunctive therapy or alternative for treatment failures. When treating PIH, any treatment options selected should be optimized and utilized carefully because the treatments itself may worsen the PIH.